Skip to main content
. 2016 Feb 15;6:21098. doi: 10.1038/srep21098

Table 2. Univariate analysis of cause specific survival.

  Median CSS 5-year CSS (95% CI) Univariate analysis P value
Log rank
Sex     4.8 0.0285
 Male 16.48 28.8 (28.0–29.6)
 Female 15.35 28.5 (27.5–29.6)
Age     10.6 0.0011
 <67 16.41 28.7 (27.5–29.3)
 >66 15.77 29.1 (28.1–30.0)
Marital status     149.37 <0.001
 Married 17.87 30.6 (29.7–31.4)
 Widowed 13.21 25.3 (24.2–27.4)
 Single 13.29 25.4 (23.7–27.1)
 Separate/Divorced 14.69 26.2 (24.2–28.2)
Race/Ethnicity     293.33 <0.001
 Caucasian 15.10 26.6 (25.9–27.4)
 African-American 14.50 26.7 (25.0–28.5)
 Asian 28.00 40.1 (38.3–41.8)
 Others 17.53 34.6 (25.5–43.9)
Insurance status     28.0 <0.001
 Uninsured 11.43 21.4 (17.3–25.8)
 Insured 16.95 29.9 (28.9–30.8)
Location     999.05 <0.001
 Cardia 16.38 25.4 (24.2–26.5)
 Fundus 13.51 24.0 (20.8–27.3)
 Body 16.77 30.9 (28.6–33.1)
 Antrum/Pylorus 23.10 37.0 (35.6–38.3)
 Lesser/Greater curvature 26.32 39.0 (37.0–40.9)
 Others 9.22 17.6 (16.4–18.8)
AJCC 6th TNM stage     9814.31 <0.001
 I 61.9 (60.6–63.2)
 II 36.82 40.9 (39.0–42.9)
 III 19.47 23.3 (21.6–25.0)
 IV 7.11 4.8 (4.3–5.3)
Lymph node removed     34.11 <0.001
 1–3 30.43 39.5 (36.3–42.7)
 >3 44.13 45.7 (44.6–46.7)
Histology subgroup     173.40 <0.001
 Signet Ring cell 12.73 21.6 (20.3–22.8)
 Mucinous adenocarcinoma 17.59 29.4 (25.5–33.4)
 Adenocarcinoma 17.45 30.8 (30.0–31.5)
Grade     682.88 <0.001
 Well differentiated 58.7 (55.1–62.2)
 Moderately differentiated 27.71 39.4 (37.9–40.8)
 Poorly differentiated 14.55 24.9 (24.1–25.7)
 Undifferentiated 14.20 22.4 (18.1–26.9)
Therapy (Surgery ± radiotherapy)     9457.52 <0.001
 Therapy 44.02 45.7 (44.8–46.6)
 None 6.24 4.4 (3.8–5.0)
 Unknown 10.37 0

CSS: Cause specific survival.

CI: Confidence interval.

AJCC: American Joint Committee on Cancer.

TNM: Tumor-Node-Metastasis.